National Account Director

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

The National Account Director will report to the Sr. Director, US Managed Markets and will lead/manage National/Regional Payer and PBM customer relationships and deliver profitable access, reimbursement, and appropriate policy for Kura brands.  The person will work collaboratively with cross functional partners in the organization including Sales, Marketing, Medical, Commercial Operations, etc.  The NAD will be responsible for helping create key communication strategies for approved therapies and assist with preapproval information exchange for products with NDA filings.  The goal of this position is to optimize ziftomenib access and develop strategies for long-term access solutions for our pipeline.

Essential Job Functions:

• In coordination with Market Access Leadership, develops a market access strategy aligned with Kura's commercial goals and ensures a comprehensive tactical plan is deployed to ensure rapid and optimal access for ziftomenib
• Establish strong networked relationships with Pharmacy Directors, Medical Directors, and other strategic personnel within target National and Regional accounts
• Create Payer Engagement plan, including participation in all relevant conferences and 1:1 meeting opportunities 
• Deliver Payer value proposition and Health Economic Information (HEI) to educate payers, formulary committees, and similar entities, on product(s) and economic benefit, pre and post FDA approval
• Create, implement, and maintain detailed account plans for targeted accounts, including pre-launch, launch, and post-launch activities to maximize access and reimbursement
• Provide appropriate insights and inputs into the development of payer PAs and, or Medical Policies
• Assess sales implications of short- and long-term actions with each payer customer and take action to move payer decisions in a direction that continues to open patient access to care with 
• Negotiate and measure contract performance (if applicable) with target accounts based on approved strategies
• Collaborate with field teams (Sales, Medical, Patient Services, etc.) to identify any access barriers and partner with colleagues to mitigate
• Work collaboratively with FRM's, HUB and Specialty Pharmacy partners to ensure reimbursement confidence and unimpeded access in alignment with product FDA label
• Provide periodic market updates to Commercial Leadership that link important provider, payer, and health care reform trends and issues as well as document initiatives and their outcomes
• Ensures all activities are consistent with all US Healthcare regulations, laws, and company compliance policies

JOB SPECIFICATIONS:

• Bachelor’s degree, MBA preferred
• Candidate should have 10+ years of proven success in biotech/pharmaceutical industry (large account management experience is preferred) that includes:
• Minimum of 10 years experience executing market access strategies for National PBM and Payer accounts, and exposure to contract development and negotiations
• Hematology and Oncology experience required
• Proven ability to gain access to key decision-makers and influencers in an accelerated fashion
• Strong understanding of the US healthcare landscape, policy, and reimbursement
• Success in building relationships with key contacts in highly matrixed organizations
• Experience negotiating and implementing pharmacy and medical policy for portfolio
• Experience delivering value propositions and using health economic models
• Deep insight into customer, policy, benefit, clinical evaluation, and legislation impact on the customer and the market
• Demonstrated ability to navigate deep into the payer/PBM, manage executive engagements, foster customer touch points within Pharmacy, Medical, policy, and reimbursement
• Strategic problem-solver; analytical and decisive
• Moves beyond the traditional ways of doing things; pushes the status quo. Continually assesses the market potential of innovative ideas and solutions and builds strong business cases for the customer and Corcept to support the initiative 
• Ability to travel up to 50% of the time for customer engagements, and internal meetings

The base range for a Director is $201,167 - $235,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.

Kura’s Values that are used for candidate selection and performance assessments:

• We work as one for patients
• We are goal-focused and deliver with excellence
• We are science-driven courageous innovators
• We strive to bring out the best in each other and ourselves

The Kura Package

• Career advancement/ development opportunities
• Competitive comp package
• Bonus
• 401K + Employer contributions
• Generous stock options
• ESPP Plan
• 20 days of PTO to start
• 18 Holidays  (Including Summer & Winter Break)
• Generous Benefits Package with a variety of plans available with a substantial employer match
• Paid Paternity/Maternity Leave
• In-Office Catered lunches
• Home Office Setup
• Lifestyle Spending Stipend
• Commuter Stipend (Boston Office)
• Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company’s diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology’s approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.

Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R/R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.